DeutschNewstral
Article
New York Post on 2024-01-04 17:50
Eli Lilly launches website, home delivery option for Wegovy alternative Zepbound
Related news
- DEli Lilly slumps after disappointing Zepbound weight-loss-drug trialdcourier.com
- Eli Lilly weight loss drug Zepbound approved by the FDANew York Post
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, MounjaroStar Tribune- MEli Lilly faucets Amazon Pharmacy to assist ship Zepbound, different medicationmvtelegraph.com
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly ReportsThe New York Times
Pharmaceuticals sector: Approval for Eli Lilly obesity drug sets up rival to WegovyFinancial Times
Eli Lilly starts website to connect patients with prescriptionsstaradvertiser.com
Eli Lilly giving price info on advertised drugs via websiteSeattle Times- Eli Lilly starts website to connect patients with new obesity treatment, Zepbound, other drugsSeattle Times
Eli Lilly wins FDA nod for obesity drug that rivals Wegovy, Ozempic - Wed, 08 Nov 2023 PSTsyndication.washingtonpost.com
Eli Lilly Exploring Elanco Spinoffwsj.com- Eli Lilly CEO to Retirewsj.com
Eli Lilly & Co. v. Perrigo Co.jdsupra.com- FAstraZeneca and Eli Lilly scrap Alzheimer’s trialft.com
- Eli Lilly & Co: Eli Lilly to seek US approval after Alzheimer’s drug trial successFinancial Times
- Eli Lilly & Co: Eli Lilly weight-loss drug found to address sleep apnoea in trialFinancial Times
- BEli Lilly Stock Falls on Data That Show Patients Who Stopped Zepbound Regained Weight1 min readbarrons.com
FDA approves Eli Lilly's diabetes drug Mounjaro for obesity under new name, ZepboundCNN- MEli Lilly (LLY) earnings This fall 2023mvtelegraph.com